Select Publications
Book Chapters
2006, 'Diagnosis and Monitoring of PML-RARα-Positive Acute Promyelocytic Leukemia by Quantitative RT-PCR', in Myeloid Leukemia, Springer Nature, pp. 127 - 147, http://dx.doi.org/10.1385/1-59745-017-0:127
,Journal articles
2024, 'Pre-market health systems barriers and enablers to infectious diseases point-of-care diagnostics in Australia: qualitative interviews with key informants', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-10214-5
,2024, 'WHO global research priorities for antimicrobial resistance in human health', The Lancet Microbe, 5, http://dx.doi.org/10.1016/S2666-5247(24)00134-4
,2024, 'Syphilis point-of-care tests: an Australian perspective', Microbiology Australia, 45, pp. 127 - 131, http://dx.doi.org/10.1071/MA24036
,2024, 'Viability of Chlamydia trachomatis in different anatomical sites - a systematic review & meta-analysis.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciae401
,2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', The Lancet Regional Health - Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101119
,2024, 'External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles', Diagnostics, 14, http://dx.doi.org/10.3390/diagnostics14111106
,2024, 'The AMR Hub: a public–private partnership to overcome barriers to commercialisation and deliver antimicrobial stewardship innovations', Microbiology Australia, 45, pp. 48 - 53, http://dx.doi.org/10.1071/MA24017
,2024, 'Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre-exposure prophylaxis in Taiwan: a modelling study', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26251
,2024, 'Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies', The Lancet HIV, 11, pp. e106 - e116, http://dx.doi.org/10.1016/S2352-3018(23)00267-9
,2024, 'Treatment ‘cultures’, sexually transmitted infections and the rise of antimicrobial resistance', Sociology of Health and Illness, http://dx.doi.org/10.1111/1467-9566.13832
,2024, 'Unnecessary antibiotic use in men who have sex with men (MSM) with anogenital symptoms attending a sexual health clinic: a retrospective analysis', Sexually Transmitted Infections, http://dx.doi.org/10.1136/sextrans-2024-056120
,2024, 'We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?', Expert Review of Molecular Diagnostics, 24, pp. 177 - 191, http://dx.doi.org/10.1080/14737159.2023.2292645
,2024, 'The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan', The Lancet regional health. Western Pacific, 48
,2023, 'National Surveillance of Home-Based HIV Testing Among Australian Gay and Bisexual Men, 2018–2020: Uptake After Commercial Availability of HIV Self-Tests', AIDS and Behavior, 27, pp. 4106 - 4113, http://dx.doi.org/10.1007/s10461-023-04124-x
,2023, 'Sex, drugs and superbugs: The rise of drug resistant STIs', SSM - Qualitative Research in Health, 4, http://dx.doi.org/10.1016/j.ssmqr.2023.100310
,2023, 'Reinfection incidence and risk among people treated for recent hepatitis C virus infection', AIDS, 37, pp. 1883 - 1890, http://dx.doi.org/10.1097/QAD.0000000000003651
,2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', The Lancet Microbe, 4, pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8
,2023, 'Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar', Viruses, 15, pp. 521, http://dx.doi.org/10.3390/v15020521
,2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733
,2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408
,2022, 'Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review', Journal of Infectious Diseases, 226, pp. 1005 - 1021, http://dx.doi.org/10.1093/infdis/jiac049
,2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
,2022, 'Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals', JHEP Reports, 4, pp. 100462, http://dx.doi.org/10.1016/j.jhepr.2022.100462
,2022, 'Preferences for HIV testing services and HIV self-testing distribution among migrant gay, bisexual and other men who have sex with men in Australia', Frontiers in Medicine, 9, pp. 839479 - 839479, http://dx.doi.org/10.3389/fmed.2022.839479
,2022, 'Supply-side readiness to deliver HIV testing and treatment services in Indonesia: Going the last mile to eliminate mother-to-child transmission of HIV.', PLOS Glob Public Health, 2, pp. e0000845, http://dx.doi.org/10.1371/journal.pgph.0000845
,2021, 'Sustaining success: a qualitative study of gay and bisexual men’s experiences and perceptions of HIV self-testing in a randomized controlled trial', BMC Public Health, 21, pp. 2048, http://dx.doi.org/10.1186/s12889-021-12011-0
,2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056
,2021, 'Evaluation of hepatitis C virus core antigen assay in a resource-limited setting in Pakistan', Diagnostics, 11, http://dx.doi.org/10.3390/diagnostics11081354
,2021, 'A decentralised point-of-care testing model to address inequities in the COVID-19 response', The Lancet Infectious Diseases, 21, pp. e183 - e190, http://dx.doi.org/10.1016/S1473-3099(20)30859-8
,2021, 'The costs of scaling up HIV and syphilis testing in low-and middle-income countries: A systematic review', Health Policy and Planning, 36, pp. 939 - 954, http://dx.doi.org/10.1093/heapol/czab030
,2021, 'Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection among People Who Inject Drugs', Clinical Infectious Diseases, 72, pp. 1392 - 1400, http://dx.doi.org/10.1093/cid/ciaa253
,2021, 'Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples', Journal of Infectious Diseases, 223, pp. 818 - 826, http://dx.doi.org/10.1093/infdis/jiaa442
,2021, 'Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples', Journal of Infectious Diseases, http://dx.doi.org/10.1093/infdis/jiaa442
,2021, 'The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial', The Lancet Regional Health - Western Pacific, 14, pp. 100214 - 100214, http://dx.doi.org/10.1016/j.lanwpc.2021.100214
,2020, 'Novel hepatitic C virus (HCV) diagnosis and treatment delivery systems: Facilitating HCV elimination by thinking outside the clinic', Journal of Infectious Diseases, 222, pp. S758 - S772, http://dx.doi.org/10.1093/infdis/jiaa366
,2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208
,2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985
,2020, 'Modeling based response guided therapy in subjects with recent hepatitis C infection', Antiviral Research, 180, http://dx.doi.org/10.1016/j.antiviral.2020.104862
,2020, 'Time to Detection of Hepatitis C Virus Infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis', Journal of Infectious Diseases, 221, pp. 2043 - 2049, http://dx.doi.org/10.1093/infdis/jiaa037
,2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, 3, http://dx.doi.org/10.1002/hsr2.151
,2020, 'Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance', Hepatology Communications, 4, pp. 904 - 915, http://dx.doi.org/10.1002/hep4.1496
,2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
,2019, 'Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study', Journal of Viral Hepatitis, 26, pp. 1423 - 1430, http://dx.doi.org/10.1111/jvh.13196
,2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112
,2019, 'Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing', Infection, Genetics and Evolution, 71, pp. 36 - 41, http://dx.doi.org/10.1016/j.meegid.2019.02.032
,2019, 'Hepatology Commissioners. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. (vol 4, pg 135, 2019)', LANCET GASTROENTEROLOGY & HEPATOLOGY, 4, pp. E4 - E4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463786300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections', Infection, Genetics and Evolution, 69, pp. 76 - 84, http://dx.doi.org/10.1016/j.meegid.2019.01.016
,2019, 'Genomic variability of within-host hepatitis C variants in acute infection', Journal of Viral Hepatitis, 26, pp. 476 - 484, http://dx.doi.org/10.1111/jvh.13051
,2019, 'Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection', JOURNAL OF HEPATOLOGY, 70, pp. E231 - E231, http://dx.doi.org/10.1016/S0618-8278(19)30432-3
,